ISA101b
HPV16+ cancers (e.g., cervical)
Phase 2Active (Partnered with Regeneron)
Key Facts
Indication
HPV16+ cancers (e.g., cervical)
Phase
Phase 2
Status
Active (Partnered with Regeneron)
Company
About ISA Pharmaceuticals
ISA Pharmaceuticals is a clinical-stage biotech leveraging its proprietary synthetic long peptide (SLP) platform to create immunotherapies targeting cancers and persistent viral infections. The company's lead programs focus on HPV-related cancers and a therapeutic vaccine for chronic hepatitis B. While still pre-revenue, ISA has established key partnerships with major pharmaceutical companies to advance its pipeline and validate its platform technology.
View full company profile